Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Ramsay Sime Darby in Talks for $500 Million China Hospital JV

publication date: Sep 30, 2016
Ramsay Sime Darby Healthcare, a Malaysian-Australian hospital operator, is in talks to form a $500 million China JV that will own two hospitals. The negotiations have reached the due diligence stage. In addition, Ramsay Sime is also discussing China hospital JVs with two other healthcare companies, though those discussions are at a much earlier level. Ramsay Sim is itself a joint venture between Malaysian conglomerate Sime Darby (which owns a healthcare subsidiary) and Australia’s largest healthcare group, Ramsay Health Care Ltd. More details....

This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital